Matsuo, K., Matsuzaki, S., Maeda, M., Rau, A.R., Yoshihara, K., Tamura, R., Shimada, M., Machida, H., Mikami, M., Klar, M., Roman, L.D., Wright, J.D., Sood, A.K. und Gershenson, D.M. (2023) Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas [cd]. Freiburg: Universität. doi:10.1001/jamanetworkopen.2023.18602.
Chicago Manual of Style 17th edition (full note)Matsuo, Koji, Shinya Matsuzaki, Michihide Maeda, Alesandra R. Rau, Kosuke Yoshihara, Ryo Tamura, Muneaki Shimada, Hiroko Machida, Mikio Mikami, Maximilian Klar, Lynda D. Roman, Jason D. Wright, Anil K. Sood, und David M. Gershenson. Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas. Cd. Freiburg: Universität, [2023?], Freiburg: Universität, [2023?]. https://doi.org/10.1001/jamanetworkopen.2023.18602.
American Psychological Association 7th editionMatsuo, K., Matsuzaki, S., Maeda, M., Rau, A. R., Yoshihara, K., Tamura, R., Shimada, M., Machida, H., Mikami, M., Klar, M., Roman, L. D., Wright, J. D., Sood, A. K., & Gershenson, D. M. (ca. 2023). Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas [Cd]. Universität. https://doi.org/10.1001/jamanetworkopen.2023.18602
Modern Language Association 9th editionMatsuo, K., S. Matsuzaki, M. Maeda, A. R. Rau, K. Yoshihara, R. Tamura, M. Shimada, H. Machida, M. Mikami, M. Klar, L. D. Roman, J. D. Wright, A. K. Sood, und D. M. Gershenson. Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas. cd, Universität, 2023, https://doi.org/10.1001/jamanetworkopen.2023.18602.
ISO-690 (author-date, Deutsch)MATSUO, Koji, Shinya MATSUZAKI, Michihide MAEDA, Alesandra R. RAU, Kosuke YOSHIHARA, Ryo TAMURA, Muneaki SHIMADA, Hiroko MACHIDA, Mikio MIKAMI, Maximilian KLAR, Lynda D. ROMAN, Jason D. WRIGHT, Anil K. SOOD und David M. GERSHENSON, 2023. Uptake and outcomes of neoadjuvant chemotherapy among US patients with less common epithelial ovarian carcinomas. Freiburg: Universität